# Comparative cardiovascular safety of GLP-1 receptor agonists versus other glucose-lowering agents in real-world patients with type 2 diabetes: a nationwide population-based cohort study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/comparative-cardiovascular-safety-of-glp-1-receptor-agonists-versus-other/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Chun‐Ting Yang,Chen-Yi Yang,Huang‐Tz Ou,Shihchen Kuo |
| Citations | 59 |
| DOI | 10.1186/s12933-020-01053-0 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://cardiab.biomedcentral.com/track/pdf/10.1186/s12933-020-01053-0 |
| OpenAlex ID | https://openalex.org/W3034514454 |
| PMID | 32534570 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Shihchen Kuo](https://scholariq.org/researchers/shihchen-kuo/)

## Paper journal

- [Cardiovascular Diabetology](https://scholariq.org/journals/cardiovascular-diabetology/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Hyperglycemia and glycemic control in critically ill and hospitalized patients](https://scholariq.org/topics/hyperglycemia-and-glycemic-control-in-critically-ill-and-hospitalized-patients/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.